[P63 protein in the diagnosis of breast tubular carcinoma].

Ann Pathol

Service d'Anatomie Pathologique, Clinique de Gynécopathologie et de Sénologie, Hôpital Universitaire Erasme, Université Libre de Bruxelles (ULB), Route de Lennik 808, 1070 Bruxelles, Belgium.

Published: September 2004

Aims: To study and compare the expression of p63 protein and smooth muscle actin in breast tubular carcinoma (TC) and its main differential diagnoses, radial scar (RS)/complex sclerosing lesion (CSL).

Materials And Methods: Immunohistochemistry techniques were used to search for p63 protein and smooth muscle actin antibodies in 10 patients with TC and fifteen with RS/CSL.

Results: Myoepythelial cells were diffusely positive for both actin and p63 protein with a cytoplasmic (actin) or nuclear (p63) pattern in all patients with RS/CSL. Inversely, all TC were negative for p63. Actin antibodies failed to label myoepithelial cells in TC, but both vessels and stromal myoblasts were actin-positive, creating difficult interpretation situations. By contrast, p63 was consistently negative in these structures.

Conclusion: For the differential diagnosis between TG and CR/LSC, smooth muscle actin and p63 protein demonstrate equivalent sensitivity for the detection of myoepithelial cells. However, the nuclear pattern of p63 labeling gives a "cleaner" stain. In addition, p63 enables distinction between myoepithelial cells and myofibroblasts/vascular smooth muscle cells, offering increased specificity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0242-6498(04)93978-8DOI Listing

Publication Analysis

Top Keywords

p63 protein
16
smooth muscle
16
muscle actin
12
myoepithelial cells
12
p63
9
breast tubular
8
protein smooth
8
actin antibodies
8
actin p63
8
actin
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!